Answer
Yes, patients taking Emtricitabine/Tenofovir Alafenamide Gilead may still develop opportunistic infections and other HIV complications, so they should remain under close observation by physicians experienced in treating HIV-associated diseases.
Sources for this answer
- Emtricitabine/Tenofovir Alafenamide Gilead 200 mg/10 mg film coated tabletsGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 25Document updated
Sources checked